Ljubljana, Slovenia 2006/Project

From 2006.igem.org

Revision as of 14:30, 28 October 2006 by Rtkavc (Talk | contribs)
Jump to: navigation, search

Line-si4.jpg

Home Background and Signalling Pathway Methods Results & Conclusions Terms & References Team members

Line-si3.jpg



Contents

Project ideas

Reasearch in the Laboratory of Biotechnology at the National institute of Chemisty, where most of our instructors come from and wheer most of the experimental work was conducted, is in the area of molecular immunology, specifically interactions in the Toll-like receptor signaling to microbial infections. This determined the selection of the eukaryotic system as our arena of synthetic biology "sandbox". besides, several contributions at the Synthetic biology meetings demonstrated that mammalian cell engineering

In the beginning we have discussed following project ideas:

  1. Inserton of a logical device into the signaling pathway to limit the cellular activation by bacterial infection - use of dominant negative versions of proteins involved in signaling pathway, which will arrest the signaling pathway thus preventing NF-κB (transcription factor mentioned above)to translocate to the nucleus - addition of degradation tags to this dominant negative proteins (PEST sequence), which would cause inhibition (negative feedback loop) to be temporal
  2. Engineering of the response to pathogens/their PAMPs, which are otherwise not recognized by cells - for example a response to beta glucans of fungi
  3. Engineering of novel interconnections between signaling pathways


Komentar: Kako se spremeni številke na za?etku - manjka št.1

Selected project

The basic idea of our project was to introduce a feedback loop in TLR signaling pathway, which would decrease the overwhelming response to the persistent or repeated stimulus with PAMP. However, completly shutting down the response to bacterial stimulation is not recommendable from the view of a host battling the infection. Ideally the feedback loop should decrease the response when it is too high but recover the responsiveness of the system after some time.

Inhibition of the overwhelming response could be achieved if PAMP is simultaneously able to activate the immune response and the expression of a dominant-negative adapter protein, that would inactivate PAMP`s signaling pathway. Decreasing the lifetime of the dominant-negative inhibitior by the addition of a rapid degradation tag (PEST sequence) should inactivate the inhibition and restore the responsiveness of the immune system.

This idea is similar to the natural mechanism of tolerance, which is already present in living cells and which decreases the response to repeated bacterial stimulations. This natural tolerance is activated slowly, on the order of days and operates through several different mechanisms (Figure). Our feedback mechanism (i.e. artificial tolerance) should decrease the response within hours and thus "attack" the signaling pathway at the point, which has not been used in the natural system.


Model of the TLR signalling triggered by bacterial infection

MyD88 is the hub of the TLR signalling pathway

Figure 1 represents the complexity of cell signalling mediated by TLRs. which contains more than 700 molecules and complexes (Oda, Kitano, Molecular Systems Biology 2006).


File:Model1.jpg.gif
Figure 1: Comprehensive scheme of the Toll-like receptor signaling of microbial infection.



MyD88 adapter protein is involved in the signal transduction immediately after ligand-induced TLR oligomerization. This adapter protein is common to most TLRs before the signaling network branches into several phosphpryation cascades. We selected this molecule as the most appropriate target of TLR signaling network engineering (Figures 2 and 3).

File:Model2.jpg.gif
Figure 2: MyD88 adapter protein connects the response of all TLRs and represents the »bottleneck« of the system (shaded area).
File:Model3.jpg.gif
Figure 3: Schematic representation of MyD88 as the hub of TLR signaling shaped like a bow tie .


Construction of the model

Model of the TLR signaling was prepared in CellDesigner. Signaling steps, where the response remains the same were assembled into one block (Signaling cascade), whose activation directly affects the NF-κB translocation. Our engineered feedback loop is inserted as a transcriptional activation of dnMyD88 protein domain (red block in Figure 5).

File:Model4.jpg.gif
Figure 4: Simplified model of Toll-like receptor signaling constructed in CellDesigner.
File:Model5.jpg.gif
Figure 5: Model of TLR signaling with additional feedback loop for the inhibition of MyD88.


Simulation of cellular response to TLR stimulation by a pulse of PAMP (e.g. flagellin). Signaling cascade results in the transient translocation of NF-κB into the cell nucleus (green) and in the production of inflammatory mediators. Repeated pulse after some time results in the repeated activation and accumulation of inflammatory mediators.


File:Model6.jpg.gif
Figure 6: Simulation of the cell response to the bacterial stimulus PAMP (grey) – transient translocation of the NF-κB into the nucleus (green), production of stimulatory mediators (orange).
File:Model7.jpg.gif
Figure 7: Simulation of the repeated stimulation by PAMP (grey) - Amount of inflammatory mediators increases (orange).


Simulation of the TLR signaling response in the system with a feedback device results in the production of inhibitor (dnMyD88, black) which inhibits cellular activation by a repeated stimulation. Cellular responsiveness resets to the normal response if the inhibitor is rapidly degraded, such as by the addition of a PEST motif.

File:Model8.jpg.gif
Figure 8: Addition of a feedback loop to start production of inhibitory dnMyD88( (black) – cell does not respond to the repeated stimulation.
File:Model9.jpg.gif
Figure 9: Feedback loop with rapid degradation of the inhibitor (dnMyD88 with PEST sequence - black) – responsiveness of the system is again completely restored.


File:Model10.jpg.gif
Figure 10: Speed of the degradation of dnMyD88 could modulate the responsiveness of the system to repeated (or continuous) challenge by TLR agonists.



Line-si4.jpg

Home Background and Signalling Pathway Methods Results & Conclusions Terms & References Team members
Line-si3.jpg
Personal tools
Past/present/future years